Supportan Drink: safety and potential benefits for cancer patients on therapy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study investigates the safety and potential benefits of Supportan Drink in cancer patients who are undergoing various cancer therapies. Eligible participants are those actively receiving treatment, while those with liver, kidney, or heart disease may be excluded at the investigator’s discretion. The study is sponsored by Fresenius Kabi Taiwan Ltd. and is located at Keelung Chang Gung Memorial Hospital’s Lover’s Lake branch in Keelung, Taiwan. Details on dosing, duration, and specific outcomes are not provided in the available information.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1\. Patients receiving chemotherapy and/or radiotherapy, or immunotherapy, or targeted therapy;

Exclusion Criteria:

1\. Patient with documented diagnosis of liver, kidney or heart disease in the hospital's electronic medical record (EMR); severity of disease evaluated by Investigator as not being suitable to participate in this study;

Where it's running

• Keelung Chang Gung Memorial Hospital-Lover's lake branch
  Keelung, Taiwan, Taiwan Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Adequacy of Middle Molecules Clearance in Haemodiafiltration and its Relation to Patient Outcomes

  This study looks at whether higher convective volumes in haemodiafiltration and different dialysate sodium levels affect toxin clearance, patient-reported outcomes, and nutritional status in adults with end-stage kidney disease.

  Recruiting East and North Hertfordshire NHS Trust · Stevenage, Hertfordshire · NCT07717255

• Child Growth Improvement program for stunting risk kids

  This study tests a community-based nutrition program with screening, education, supplementation, and follow-up to help 1–5 year-olds at risk of stunting.

  Recruiting Abbott Nutrition · Kansas City, Missouri · NCT07524907

• Using REMS ultrasound to check bone density in children and teens with conditions that lower bone strength

  This project will test whether REMS, a radiation-free ultrasound method, can measure bone mineral density in children and adolescents aged 5–18 who have conditions that weaken their bones.

  Recruiting Meyer Children's Hospital IRCCS · Florence, Tuscany · NCT07412782

• Screening for Malnutrition and Sarcopenia in Outpatients

  This project will screen adult outpatients (18+) in hospital clinics in Turkey to see how common the risk of malnutrition and sarcopenia is.

  Recruiting at 69 sites Abbott Nutrition · Sarıçam, Adana and 68 other locations · NCT07256925

• Optimizing Cancer Treatment with EPA-enriched Nutrition for Malnutrition

  This trial tests whether EPA-enriched nutrition helps undernourished adults with stage III–IV lung or colorectal cancer who are starting or receiving systemic cancer therapy.

  Recruiting at 3 sites University of Edinburgh · Oslo and 3 other locations · NCT07255066

• Goat milk–derived formula versus undiluted goat milk for infants who cannot be exclusively breastfed: growth and gut health

  This study will test whether a goat milk–derived formula is safe and supports similar growth and gut health for 8–10 week old infants who cannot be exclusively breastfed, compared with undiluted goat milk or breast milk.

  Recruiting Aga Khan University · Matiāri, Sindh · NCT07225153

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.